Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence of de Novo Hepatocellular Carcinoma After Direct-acting Antiviral Agents for HCV: a Multicenter Prospective Cohort Study From Latin America.

NCT03775798 is registered in ClinicalTrials.gov with Austral University, Argentina as lead sponsor.

NCT NCT03775798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03775798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence of de Novo Hepatocellular Carcinoma After Direct-acting Antiviral Agents for HCV: a Multicenter Prospective Cohort Study From Latin America.
Lead sponsor
Austral University, Argentina
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2016
Completion date
January 1, 2021
Enrollment
2,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiviral drug adverse reaction, cirrhosis, hepatitis c